CarelabsLtd Past Earnings Performance
Past criteria checks 0/6
CarelabsLtd's earnings have been declining at an average annual rate of -67.1%, while the Healthcare Services industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 4.7% per year.
Key information
-67.1%
Earnings growth rate
-66.2%
EPS growth rate
| Healthcare Services Industry Growth | 16.7% |
| Revenue growth rate | 4.7% |
| Return on equity | -30.5% |
| Net Margin | -30.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
There Is A Reason Carelabs Co.,Ltd's (KOSDAQ:263700) Price Is Undemanding
Nov 12
The Market Doesn't Like What It Sees From Carelabs Co.,Ltd's (KOSDAQ:263700) Revenues Yet
Aug 07We Think CarelabsLtd (KOSDAQ:263700) Has A Fair Chunk Of Debt
Jun 12Carelabs Co.,Ltd (KOSDAQ:263700) Held Back By Insufficient Growth Even After Shares Climb 50%
Feb 27Revenue & Expenses Breakdown
How CarelabsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 80,502 | -24,327 | 79,901 | 3,068 |
| 31 Mar 24 | 81,181 | -23,662 | 82,346 | 3,449 |
| 31 Dec 23 | 81,827 | -24,470 | 82,452 | 3,811 |
| 30 Sep 23 | 82,468 | -26,232 | 81,951 | 3,849 |
| 30 Jun 23 | 85,203 | -24,466 | 81,697 | 3,583 |
| 31 Mar 23 | 87,341 | -26,659 | 82,780 | 3,192 |
| 31 Dec 22 | 87,607 | -26,124 | 83,841 | 2,767 |
| 30 Sep 22 | 91,259 | -13,679 | 85,241 | 2,895 |
| 30 Jun 22 | 93,658 | -8,170 | 84,979 | 3,033 |
| 31 Mar 22 | 95,413 | -1,682 | 82,975 | 3,275 |
| 31 Dec 21 | 93,934 | 1,253 | 79,994 | 3,502 |
| 30 Sep 21 | 89,878 | 2,251 | 75,574 | 3,280 |
| 30 Jun 21 | 85,358 | 3,635 | 71,296 | 2,878 |
| 31 Mar 21 | 79,520 | 5,377 | 65,929 | 2,744 |
| 31 Dec 20 | 76,666 | 4,329 | 62,034 | 2,743 |
| 30 Sep 20 | 73,495 | 4,234 | 59,292 | 2,796 |
| 30 Jun 20 | 71,239 | 2,761 | 57,297 | 3,133 |
| 31 Mar 20 | 70,613 | 1,626 | 56,961 | 3,233 |
| 31 Dec 19 | 68,300 | 583 | 56,564 | 3,096 |
| 30 Sep 19 | 66,419 | 1,189 | 56,522 | 2,875 |
| 30 Jun 19 | 64,452 | 1,819 | 55,138 | 2,479 |
| 31 Mar 19 | 58,379 | 2,109 | 50,193 | 2,194 |
| 31 Dec 18 | 54,379 | 3,554 | 46,143 | 1,830 |
| 30 Sep 18 | 49,548 | 4,453 | 40,061 | 1,905 |
| 30 Jun 18 | 45,004 | 4,456 | 35,845 | 1,755 |
| 31 Mar 18 | 42,684 | 4,849 | 33,480 | 1,753 |
| 31 Dec 17 | 39,336 | 4,788 | 30,919 | 1,428 |
| 30 Sep 17 | 37,314 | 4,999 | 29,867 | 798 |
| 31 Dec 16 | 18,597 | 1,935 | 16,330 | 0 |
Quality Earnings: A263700 is currently unprofitable.
Growing Profit Margin: A263700 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A263700 is unprofitable, and losses have increased over the past 5 years at a rate of 67.1% per year.
Accelerating Growth: Unable to compare A263700's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A263700 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (10.2%).
Return on Equity
High ROE: A263700 has a negative Return on Equity (-30.52%), as it is currently unprofitable.